Key result
Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy requires a multimodal approach including ECG, echocardiography, cardiac magnetic resonance, and genetic testing to prevent sudden cardiac death.
Why the study?
Hypertrophic cardiomyopathy is a leading cause of sudden death in young athletes under 35 years and can resemble athlete's heart, requiring accurate differentiation to avoid life-threatening events or unnecessary termination of athletic careers.
Accurate differentiation between athlete's heart and hypertrophic cardiomyopathy is essential to prevent sudden cardiac death in young athletes without unnecessarily ending their athletic careers.
Answers are grounded in this paper and cite their sources.
Distinguishing HCM from athlete's heart prevents sudden death and unwarranted sports bans; leaves open refined multimodal criteria in equivocal cases.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
M Bláha (2020) conducted a review in Hypertrophic cardiomyopathy and athlete's heart. Differential diagnostics (ECG, Echocardiography, MRI, Genetic testing) was evaluated. Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy requires a multimodal approach including ECG, echocardiography, cardiac magnetic resonance, and genetic testing to prevent sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: